ATARA BIOTHERAPEUTICS, INC. Stock-Based Compensation
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Stock-Based Compensation of $1.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $394.00K, a 85.93% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $749.00K, a 82.20% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.52M, a 74.05% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.23M, a 80.92% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $9.75M, a 63.88% decline from fiscal 2024.
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $27.00M, a 40.51% decline from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $45.39M, a 15.70% decline from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $53.84M, a 0.05% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.14M 10-Q · filed 2026-08-12 | $2.66M derived: sum of 3 quarters · filed 2026-08-12 | $3.88M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $749.00K 10-Q · filed 2026-05-12 | $2.27M derived: sum of 2 quarters · filed 2026-05-12 | $3.49M derived: sum of 3 quarters · filed 2026-05-12 | $6.29M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.74M derived: sum of 2 quarters · filed 2026-03-16 | $5.54M derived: sum of 3 quarters · filed 2026-08-12 | $9.75M 10-K · filed 2026-03-16 |
| 2025-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.03M derived: sum of 2 quarters · filed 2026-08-12 | $8.23M 10-Q · filed 2025-11-12 | $14.08M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $7.01M 10-Q · filed 2026-08-12 | $12.86M derived: sum of 3 quarters · filed 2026-08-12 | $19.28M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $4.21M 10-Q · filed 2026-05-12 | $10.05M derived: sum of 2 quarters · filed 2026-05-12 | $16.48M derived: sum of 3 quarters · filed 2026-05-12 | $22.81M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $12.27M derived: sum of 2 quarters · filed 2026-03-16 | $18.60M derived: sum of 3 quarters · filed 2026-03-16 | $27.00M 10-K · filed 2026-03-16 |
| 2024-09-30 | $6.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $12.76M derived: sum of 2 quarters · filed 2025-11-12 | $21.16M 10-Q · filed 2025-11-12 | $31.08M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $14.73M 10-Q · filed 2025-08-11 | $24.66M derived: sum of 3 quarters · filed 2025-08-11 | $35.80M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $8.40M 10-Q · filed 2025-05-15 | $18.32M derived: sum of 2 quarters · filed 2025-05-15 | $29.47M derived: sum of 3 quarters · filed 2025-05-15 | $42.02M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $21.07M derived: sum of 2 quarters · filed 2025-03-07 | $33.62M derived: sum of 3 quarters · filed 2025-03-07 | $45.39M 10-K · filed 2025-03-07 |
| 2023-09-30 | $11.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $23.70M derived: sum of 2 quarters · filed 2024-11-12 | $35.46M 10-Q · filed 2024-11-12 | $46.82M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $12.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $24.32M 10-Q · filed 2024-08-12 | $35.68M derived: sum of 3 quarters · filed 2024-08-12 | $49.70M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $11.76M 10-Q · filed 2024-05-09 | $23.13M derived: sum of 2 quarters · filed 2024-05-09 | $37.15M derived: sum of 3 quarters · filed 2024-05-09 | $51.27M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $25.39M derived: sum of 2 quarters · filed 2024-03-28 | $39.50M derived: sum of 3 quarters · filed 2024-03-28 | $53.84M 10-K · filed 2024-03-28 |
| 2022-09-30 | $14.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $28.14M derived: sum of 2 quarters · filed 2023-11-01 | $42.48M 10-Q · filed 2023-11-01 | $56.50M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $14.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $28.45M 10-Q · filed 2023-08-08 | $42.48M derived: sum of 3 quarters · filed 2023-08-08 | $56.24M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $14.34M 10-Q · filed 2023-05-08 | $28.36M derived: sum of 2 quarters · filed 2023-05-08 | $42.13M derived: sum of 3 quarters · filed 2023-05-08 | $55.93M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $14.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $27.79M derived: sum of 2 quarters · filed 2023-02-08 | $41.60M derived: sum of 3 quarters · filed 2023-02-08 | $53.87M 10-K · filed 2023-02-08 |
| 2021-09-30 | $13.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $27.57M derived: sum of 2 quarters · filed 2022-11-08 | $39.84M 10-Q · filed 2022-11-08 | $51.34M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-06-30 | $13.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $26.07M 10-Q · filed 2022-08-08 | $37.58M derived: sum of 3 quarters · filed 2023-02-08 | $50.83M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-03-31 | $12.27M 10-Q · filed 2022-05-05 | $23.77M derived: sum of 2 quarters · filed 2023-02-08 | $37.03M derived: sum of 3 quarters · filed 2023-02-08 | $50.98M derived: sum of 4 quarters · filed 2023-02-08 |
| 2020-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $24.76M derived: sum of 2 quarters · filed 2023-02-08 | $38.71M derived: sum of 3 quarters · filed 2023-02-08 | $51.35M 10-K · filed 2023-02-08 |
| 2020-09-30 | $13.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $27.20M derived: sum of 2 quarters · filed 2021-11-04 | $39.85M 10-Q · filed 2021-11-04 | $51.92M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $13.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $26.59M 10-Q · filed 2021-08-09 | $38.67M derived: sum of 3 quarters · filed 2022-02-28 | $50.82M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $12.64M 10-Q · filed 2021-05-04 | $24.72M derived: sum of 2 quarters · filed 2022-02-28 | $36.87M derived: sum of 3 quarters · filed 2022-02-28 | $52.07M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $12.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $24.23M derived: sum of 2 quarters · filed 2022-02-28 | $39.43M derived: sum of 3 quarters · filed 2022-02-28 | $51.70M 10-K · filed 2022-02-28 |
| 2019-09-30 | $12.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $27.35M derived: sum of 2 quarters · filed 2020-11-09 | $39.62M 10-Q · filed 2020-11-09 | $49.17M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $27.47M 10-Q · filed 2020-08-05 | $37.02M derived: sum of 3 quarters · filed 2021-03-01 | $46.27M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $12.27M 10-Q · filed 2020-05-06 | $21.82M derived: sum of 2 quarters · filed 2021-03-01 | $31.07M derived: sum of 3 quarters · filed 2021-03-01 | $39.07M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $9.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $18.80M derived: sum of 2 quarters · filed 2021-03-01 | $26.80M derived: sum of 3 quarters · filed 2021-03-01 | $33.82M 10-K · filed 2021-03-01 |
| 2018-09-30 | $9.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $17.25M derived: sum of 2 quarters · filed 2019-11-07 | $24.26M 10-Q · filed 2019-11-07 | $30.36M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $15.01M 10-Q · filed 2019-08-08 | $21.11M derived: sum of 3 quarters · filed 2020-02-27 | $27.11M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $7.01M 10-Q · filed 2019-05-09 | $13.11M derived: sum of 2 quarters · filed 2020-02-27 | $19.11M derived: sum of 3 quarters · filed 2020-02-27 | $24.77M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $12.10M derived: sum of 2 quarters · filed 2020-02-27 | $17.75M derived: sum of 3 quarters · filed 2020-02-27 | $23.10M 10-K · filed 2020-02-27 |
| 2017-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $11.66M derived: sum of 2 quarters · filed 2018-11-06 | $17.00M 10-Q · filed 2018-11-06 | $18.66M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $11.00M 10-Q · filed 2018-08-01 | $12.66M derived: sum of 3 quarters · filed 2019-02-26 | $17.93M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $5.35M 10-Q · filed 2018-05-08 | $7.00M derived: sum of 2 quarters · filed 2019-02-26 | $12.27M derived: sum of 3 quarters · filed 2019-02-26 | $17.41M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $6.92M derived: sum of 2 quarters · filed 2019-02-26 | $12.06M derived: sum of 3 quarters · filed 2019-02-26 | $16.78M 10-K · filed 2019-02-26 |
| 2016-09-30 | $5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $10.40M derived: sum of 2 quarters · filed 2017-11-09 | $15.13M 10-Q · filed 2017-11-09 | $18.09M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $9.86M 10-Q · filed 2017-08-07 | $12.82M derived: sum of 3 quarters · filed 2018-02-27 | $15.06M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $4.72M 10-Q · filed 2017-05-04 | $7.69M derived: sum of 2 quarters · filed 2018-02-27 | $9.92M derived: sum of 3 quarters · filed 2018-02-27 | $12.49M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.20M derived: sum of 2 quarters · filed 2018-02-27 | $7.77M derived: sum of 3 quarters · filed 2018-02-27 | $10.25M 10-K · filed 2018-02-27 |
| 2015-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $4.80M derived: sum of 2 quarters · filed 2016-11-04 | $7.29M 10-Q · filed 2016-11-04 | $13.06M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $5.05M 10-Q · filed 2016-08-08 | $10.83M derived: sum of 3 quarters · filed 2017-03-09 | $11.31M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $2.48M 10-Q · filed 2016-05-06 | $8.26M derived: sum of 2 quarters · filed 2017-03-09 | $8.74M derived: sum of 3 quarters · filed 2017-03-09 | |
| 2014-12-31 | $5.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $6.26M derived: sum of 2 quarters · filed 2017-03-09 | $10.10M 10-K · filed 2017-03-09 | |
| 2014-09-30 | $484.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.33M 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $3.84M 10-Q · filed 2015-08-07 | |||
| 2013-12-31 | $696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $1.71M 10-K · filed 2016-03-04 | ||
| 2013-09-30 | $1.02M 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |